Diurnal Group PLC

Just over a month after getting US approval for Zoryve, a topical cream for psoriasis, Arcutis Biotherapeutics, Inc. is now targeting atopic dermatitis with the proposed purchase of the UK's Ducent

Diurnal Group PLC 's dream to remain independent and become a fully integrated firm has failed to materialize, with the UK biotech being bought by Neurocrine Biosciences, Inc. of the US for £48.3m (

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sanofi Hopes Owkin Can Aid Oncology Dis

Heartseed Gets $55m Up Front Japanese bioventure Heartseed Inc. and Novo Nordisk A/S announced a worldwide collaboration and license agreement on 1 June for the development, manufacture and commer